Advisor(s)
Abstract(s)
In the current study, we explored for the first time, the mechanism of action of the new Casein kinase 1 ε (CK1ε) selective inhibitor
GSD0054. Although GSD0054 behaved as a selective CK1ε inhibitor in enzymatic assays, we studied whether this inhibitory
activity also occurred inside the cells. The effects of GSD0054 on β-catenin expression and disruption of cell cycle progression
were studied in the human breast cancer cell lines MDA-MB-453 (β-catenin negative) and T-47D (β-catenin positive). We also
performed molecular modeling studies using computational docking against CK1ε to explain and predict the mechanism of
action of this compound. Moreover, the commercially available CK1ε inhibitor PF-4800567 and the CK1δ/ε inhibitors PF-670462
and IC261 were also studied for comparison purposes. GSD0054 showed anti-proliferative activity against MDA-MB-453 and
T-47D cells despite the fact that MDA-MB-453 cells do not possess active β-catenin. However, selective cell killing occurred in
the more resistant, β-catenin active, T-47D cells. CK1ε was confirmed as a cellular target, although other targets or alternative
mechanisms of action could possibly explain the anti-proliferative activity in MDA-MB-453 cells.
Description
Keywords
Synthetic lethality Casein kinase inhibitors Wnt/beta-catenin Anti-beta-amino alcohols Breast cancer . Faculdade de Ciências Exatas e da Engenharia
Citation
Lagunes, I., Martín-Batista, E., Silveira-Dorta, G., Fernandes, M. X., & Padrón, J. M. (2018). Differential mechanism of action of the CK1ε inhibitor GSD0054. Journal of Molecular and Clinical Medicine, 1(2), 77-84.
Publisher
IMR Press